Many drugs are dosed in milligrams per kilogram, scaled carefully to a person's size because the medicine circulates through the bloodstream and needs to reach a target concentration in tissue. Mebendazole works differently, and that difference is the whole story of how it's actually dosed. This article explains what the real dosing schedules are for pinworm and other intestinal worm infections, why body weight plays a much smaller role than most people assume, and where weight and age genuinely do matter.
The dose that actually appears on the label
For the common indications - pinworm (enterobiasis), roundworm (ascariasis), whipworm (trichuriasis), and hookworm - mebendazole is prescribed as a flat, fixed dose for essentially everyone over two years of age, adults included. There is no chart matching kilograms to milligrams for the standard tablet strength, because none is needed.
- Pinworm (Enterobius vermicularis): a single 100 mg dose, taken once, for anyone two years of age or older. Adults and children receive the identical dose.
- Roundworm, whipworm, hookworm, or mixed infections: 100 mg taken twice daily (morning and evening) for three consecutive days, again the same for adults and children over two.
- Repeat dosing for pinworm: many clinicians recommend a second single 100 mg dose two to three weeks after the first, not because the drug wore off, but because of how pinworm reinfects a household (explained below).
This is worth sitting with for a moment, because it runs against the intuition that "bigger person, bigger dose" always applies in medicine. A 20-kilogram child and a 90-kilogram adult take the same 100 mg tablet. That is not an oversight in the labeling; it reflects how the drug actually behaves once swallowed.
Why the body's size barely matters here
Mebendazole is a benzimidazole compound, chemically related to other members of a class first developed from work on soil and agricultural fungicides in the 1960s - a reminder that some of the most useful antiparasitic tools have come from careful observation of ordinary organisms already at work in the created world. Its mechanism is mechanically simple: it binds to beta-tubulin, a structural protein worms need to build the microtubules that keep their cells intact and allow them to absorb glucose. Deprived of functioning microtubules, the worm's energy metabolism collapses over one to three days and it dies and is passed in the stool.
Crucially, mebendazole does its work almost entirely inside the intestinal lumen, where the worms live, rather than after being absorbed into the bloodstream. Pharmacokinetic studies going back to the 1970s and 1980s found that less than 10 percent of an oral dose is absorbed systemically, and what little is absorbed undergoes extensive first-pass metabolism in the liver before being cleared. Taking the tablet with a fatty meal roughly doubles absorption, but for a drug meant to act on worms sitting in the gut rather than in tissue, higher blood levels are not the goal and are not required for the medicine to work.
This is precisely why weight-based dosing, which exists to control blood concentration relative to a person's volume of distribution, isn't the driving variable. A child's gut and an adult's gut both need enough drug present at the mucosal surface long enough to disable the parasites living there; a 100 mg dose reliably achieves that regardless of whether the person weighs 15 kilograms or 90.
Where weight and age genuinely change the picture
None of this means body size is irrelevant everywhere mebendazole is used. It matters in a few specific, well-defined situations.
- Children under two years old: mebendazole is generally not recommended in this age group. Efficacy and safety data are limited, and infections of this kind are also less common and often harder to confirm in infants, so most guidelines advise a physician's individual judgment rather than a standard fixed dose.
- Mass deworming programs: the World Health Organization's community-based deworming initiatives, which treat millions of school-age children in regions where soil-transmitted worms are endemic, use age bands rather than individual weighing - typically a full 500 mg single dose for children over roughly two years and a reduced dose for those between one and two years. This is a population health tool operating at enormous scale, not a substitute for individualized medical dosing.
- Systemic or tissue-invasive infections such as hydatid disease (echinococcosis) or trichinellosis, which are far less common and generally treated with higher, extended, and sometimes weight-adjusted regimens under specialist supervision, occasionally alongside or instead of albendazole. These are not the "take one tablet" scenario most readers searching for mebendazole dosing actually have in mind, and mebendazole is not the first-line choice for most of these conditions in current practice.
If a prescription or product label describes a dose calculated from a child's weight in kilograms, it is worth asking the prescribing physician or pharmacist directly what condition is being treated, since that pattern points toward one of these less common scenarios rather than routine pinworm or roundworm treatment.
Why the two-week repeat dose exists
The recommendation to repeat a pinworm dose after two to three weeks confuses some readers into assuming the first dose "didn't work" or that dosing should be titrated upward. Neither is true. Pinworm eggs are extraordinarily good at surviving on hands, under fingernails, on bedding, and on household surfaces, remaining infective for roughly two to three weeks. A single dose kills the adult worms present at the time of treatment, but it does nothing to eggs already laid, which can hatch and reinfect the same person or other household members days later. The second dose is timed to catch that next generation before it matures and lays eggs of its own, which is why household-wide treatment and attention to hand hygiene and laundering of bedding matter alongside the medication itself. This is a life-cycle problem, not a pharmacokinetic one, and no amount of increasing the milligram dose changes it.
Safety, pregnancy, and working with your physician
Because mebendazole's systemic exposure is low, it is generally well tolerated, with mild gastrointestinal upset being the most common complaint. Two safety points deserve direct attention. First, animal studies conducted decades ago found that high doses given to pregnant rats early in gestation were associated with fetal loss and skeletal abnormalities. While there isn't strong human data proving harm at the low, brief doses used for pinworm, most current guidance advises avoiding mebendazole during the first trimester of pregnancy and using it in later pregnancy only when a physician judges the benefit clearly outweighs the risk. This is a case where caution for an unseen, developing life is entirely appropriate, and it is exactly the kind of decision that belongs between a woman and her own physician rather than being made casually.
Second, mebendazole is metabolized through liver enzymes that can be affected by other medications - cimetidine can raise mebendazole levels, while drugs like carbamazepine or phenytoin can lower them - so anyone on regular prescription medication should mention it before treatment.
On the population level, a Cochrane systematic review examining deworming programs in children (led by researchers including D. Taylor-Robinson, last substantially updated in the mid-2010s) found that mass deworming reliably reduces worm burden but that evidence for downstream benefits like improved growth or school performance was inconsistent and, in many included trials, weak. That is a fair example of good evidence for one outcome (killing the worms) and genuinely uncertain evidence for another (broader child development), and both deserve to be described honestly rather than blurred together.
For an individual family dealing with a suspected pinworm infection, the practical takeaway is straightforward: this is a medicine with a simple, well-established fixed dose, a clear mechanism, and a track record spanning decades of use. Understanding why the dose is fixed - rather than assuming a chart must exist somewhere matching kilograms to milligrams - helps a parent or patient ask better questions of their physician or pharmacist and make an informed decision rather than guessing.
Key takeaway: Mebendazole's standard dose is fixed at 100 mg regardless of body weight because it acts locally in the gut with minimal absorption into the bloodstream, and weight or age only change the picture in infants under two, mass deworming programs, and rarer tissue-invasive infections best managed directly with a physician.